GRI Bio Corp - GRI Projected Future Earnings
GRI Bio, Inc. (GRI) is developing an NKT cell-based immunological network for the early containment of organ fibrosis. This chart on GURU.Markets shows that the current level of projected profit has reached a value where the 0.00 mark records this indicator. This is based on the absence of geopolitical threats in the US and the success of the GRI-0621 candidate in clinical trials for the treatment of the lungs and liver.
Analytical breakdowns and data insights for company GRI Bio Inc (GRI)
- stock quotes and analyst forecast:
- issuer market value details:
- book capitalization indicators:
- debt and liquidity data:
- net income and valuation ratios data:
GRI - Final Profit|Projected Future Earnings GRI Bio, Inc.|GRI - Business Payback Period|Projected Price to Earnings GRI Bio|GRI - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple GRI Bio|GRI - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) GRI Bio|GRI - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months gribio.com|GRI - Earnings per share growth rate in current year|Expected earnings per share growth for next year GRI Bio, Inc.
- sales volume and revenue indicators:
General company analysis:GRI Bio, Inc., GRI
The capitalization dynamics of GRI Bio, Inc. (GRI) depend directly on the market valuation of its NKT-cell development efficiency. This indicator calculates the discounted value of future cash flows, eliminating the time gap between quarterly reports. By analyzing the company's expected financial results, investors can gauge the market's aggregate confidence in the commercialization of fibrous disease therapies. The upward trend confirms the value of the recruited immunology staff, while peak values signal that positive sentiment is fully priced in.
Competitors of GRI Bio, Inc.
Future Profit ARGX|BNTX: Expected Net Income|Projected Future Earnings ABVX|Company Profit Forecast ADMA Biologics Inc|Expected Profit Protagonist Therapeutics Inc PTGX|IMVT - Future Profit|KNSA - Expected Profit|grifols.com (GRFS) - Future Profit|ADPT (Adaptive Biotechnologies Corporation) - Future Profit|Celldex Therapeutics Inc (CLDX) - Projected Future Earnings|Expected Profit Aurinia Pharma|Net Profit Forecast BCRX (BioCryst Corp)|Projected Future Earnings VERA|DNTH - Expected Net Profit|Projected Future Earnings PHVS (Pharvaris)|Projected Net Profit AbCellera Corp|TRML - Expected Profit|Expected Net Income PGEN (Precigen Corp)|PHAR: Projected Future Earnings|NKTR - Company Profit Forecast|Future Profit UPB|ZBIO: Expected Net Income|Projected Future Earnings IMNM|Expected Profit GOSS (Gossamer Bio Corp.)|Projected Future Earnings KALV (KalVista Pharmaceuticals)|Company Profit Forecast septerna.com (SEPN)|PVLA - Expected Profit|Expected Net Profit Savara Inc|RIGL (Rigel Pharmaceuticals Inc) - Future Profit|AnaptysBio Inc. - Expected Net Income|ATXS (Astria Therapeutics) - Projected Future Earnings|engene.com (ENGN) - Company Profit Forecast|Expected Profit RAPT Therapeutics (RAPT)|aerovatetx.com - Net Profit Forecast|Projected Future Earnings ACRS (Aclaris)|KYTX - Future Profit|TLSA: Future Profit|Company Profit Forecast cabalettabio.com CABA|VTYX: Projected Future Earnings|Projected Net Profit Theratechnologies, Inc. THTX|Expected Profit Avalo Therapeutics Inc.|ELDN: Expected Net Income|Projected Future Earnings AGEN|Company Profit Forecast climbbio.com|Expected Profit Zura Bio ZURA|ATYR (aTyr Pharma Inc) - Forward Earnings|Adagene Corp - Projected Future Earnings|Expected Net Income IMA (ImageneBio Inc)|STTK: Projected Future Earnings|Equillium (EQ) - Projected Future Earnings|Expected Profit Connect Biopharma Holdings|IMUX: Expected Net Income|Expected Profit Atara Biotherapeutics (ATRA)|Future Profit inflarx.de IFRX|Projected Future Earnings XFOR (X4 Pharmaceuticals)|Projected Future Earnings Adicet Bio Inc. ACET|CELU: Future Profit|Expected Net Income INMB (INmune Bio Inc)|BRNS: Projected Future Earnings|KZR - Company Profit Forecast|Expected Profit SAB Biotherapeutics|Future Profit akaritx.com (AKTX)|Expected Profit Enlivex Therapeutics (ENLV)|Future Profit q32bio.com QTTB|GeoVax Labs Inc - Future Profit|Projected Future Earnings Edesa Biotech Corp EDSA|IBIO - Expected Profit|CARM (Carisma Therapeutics) - Net Profit Forecast|XTLB: Projected Future Earnings|Expected Net Profit Bolt Biotherapeutics, Inc. (BOLT)|HCWB (HCW Biologics, Inc.) - Projected Future Earnings|APVO - Projected Net Profit|Expected Profit AIM ImmunoTech Inc. (AIM)|ADTX (aditxt.com) - Expected Net Income|Projected Future Earnings XRTX (XORTX Therapeutics)|Company Profit Forecast Vyome Holdings Inc. (HIND)|REVB: Future Profit|Expected Net Income INDP (Indaptus Corp)|SCNI: Projected Future Earnings|CALI (CalciMedica) - Expected Profit|AFMD (Affimed NV) - Projected Future Earnings|Allakos Therapeutics (ALLK) - Company Profit Forecast|Expected Profit HOOKIPA Pharma Inc. (HOOK)|IGMS - Expected Net Profit|iTeos Therapeutics - Future Profit|Expected Net Income OCEA|TC BioPharm - Projected Future Earnings|Company Profit Forecast Third Harmonic Bio Inc. THRD
